• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Data Knights Acquisition Corp. (Amendment)

    2/14/23 4:22:59 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Get the next $DKDCA alert in real time by email
    SC 13G/A 1 karpus-sch13g_18686f.htm KARPUS INVESTMENT MGT / DATA KNIGHTS ACQUISITION - SCHEDULE 13G/A(#1E)

     

      

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

      (Amendment No. 1) *

     

     

    Data Knights Acquisition Corp.

    (Name of Issuer)

       

    Common

     

    (Title of Class of Securities)

      

    237699103

     

    (CUSIP Number)

      

    December 31, 2022

     

    (Date of Event Which Requires Filing of This Statement)

     

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒   Rule 13d-1(b)

    ☐   Rule 13d-1(c)

    ☐   Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     
     

    CUSIP No.  237699103

    13G Page 2 of 5 Pages    

    1.  

    NAME OF REPORTING PERSON(S)

     

    Karpus Investment Management

     

       
    2.  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

     

     

    (a) ☐

    (b) ☒

    3.  

    SEC USE ONLY

     

     

     

       
    4.  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    New York 

      

       
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY EACH
    REPORTING
    PERSON WITH
     

     5.

     

    SOLE VOTING POWER

     

    0 Shares

     

      6.  

    SHARED VOTING POWER

     

    0 Shares

     

      7.  

    SOLE DISPOSITIVE POWER

     

    0 Shares

     

      8.  

    SHARED DISPOSITIVE POWER

     

    0 Shares

     

    9.  

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0 Shares

     

       
    10.  

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

     

       ☐
    11.  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

      

    0%

     

       

     12.

     

    TYPE OF REPORTING PERSON

       

    IA

     

       

     

     
     

    CUSIP No.  237699103

    13G Page 3 of 5 Pages    

     

     

    Item 1(a). Name of Issuer:

     

    Data Knights Acquisition Corp.

     

     

     

    Item 1(b). Address of Issuer's Principal Executive Offices:

     

    Trident Court, 1 Oakcroft Road, Chessington, KT9 1BD, United Kingdom

     

     

     

    Item 2(a). Name of Person Filing:

     

    This statement is being filed by Karpus Management, Inc., d/b/a Karpus Investment Management (“Karpus” or the “Reporting Person”). Karpus is a registered investment adviser under Section 203 of the Investment Advisers Act of 1940. Karpus is controlled by City of London Investment Group plc (“CLIG”), which is listed on the London Stock Exchange. However, in accordance with SEC Release No. 34-39538 (January 12, 1998), effective informational barriers have been established between Karpus and CLIG such that voting and investment power over the subject securities is exercised by Karpus independently of CLIG, and, accordingly, attribution of beneficial ownership is not required between Karpus and CLIG.

     

    The Shares to which this Schedule 13G relates are owned directly by the accounts managed by Karpus.

     

     

     

    Item 2(b). Address of Principal Business Office or, if none, Residence:

     

    183 Sully's Trail, Pittsford, New York 14534.

     

     

     

    Item 2(c). Citizenship:

     

    The members of the Karpus Management Committee are US citizens. Karpus is a New York corporation.

     

     

     

    Item 2(d). Title of Class of Securities.

     

    Common

     

     

     

    Item 2(e). CUSIP Number.

     

    237699103

     

     

      

    Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a)  ☐ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);

     

    (b)  ☐ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
     
    (c)  ☐ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
     
    (d)  ☐ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
     
    (e)  ☒ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
     
    (f)  ☐ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
     
    (g)  ☐ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
     
    (h)  ☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
     
    (i)  ☐

    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

     

      (j) ☐  A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
     
    (k)  ☐ Group, in accordance with §240.13d-1(b)(1)(ii)(K).

     
     

    CUSIP No.  237699103

    13G Page 4 of 5 Pages    

     

     

    Item 4. Ownership:

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

    (a)       Amount beneficially owned:   0

    (b)       Percent of Class:    0%

    (c)       Number of shares as to which such person has:

    (i)     Sole power to vote or direct the vote:    0

    (ii)    Shared power to vote or direct the vote:     0

    (iii)   Sole power to dispose or to direct the disposition of:    0

    (iv)   Shared power to dispose or to direct the disposition of:     0

     

     

     

    Item 5. Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date herof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:   ☒

     

      

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

     

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security being Reported on by the Parent Holding Company.

     

    Not applicable.

     

     

     

    Item 8. Identification and Classification of Members of the Group.

     

    Not applicable.

     

     

     

    Item 9. Notice of Dissolution of Group.

     

    Not applicable.

     

     

     

    Item 10. Certification.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     
     

    CUSIP No.  237699103

    13G Page 5 of 5 Pages    

     

     

    SIGNATURES

    After reasonable inquiry and to the best of his knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

    Dated:                February 14, 2023

     

     
    KARPUS MANAGEMENT, INC.

     
           
    By:
    /s/ Jodi L.Hedberg  
        Name:  Jodi L. Hedberg  
        Title:    Chief Compliance Officer  
           

     

     

     

     

     

     

     

     

     

     

     

     

     

    Get the next $DKDCA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DKDCA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DKDCA
    SEC Filings

    View All

    Data Knights Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - OneMedNet Corp (0001849380) (Filer)

    2/9/24 4:15:31 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    SEC Form S-1 filed by Data Knights Acquisition Corp.

    S-1 - OneMedNet Corp (0001849380) (Filer)

    12/18/23 8:29:14 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Data Knights Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - OneMedNet Corp (0001849380) (Filer)

    11/22/23 5:30:12 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $DKDCA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Casey Paul claimed ownership of 599,172 shares (SEC Form 3)

    3 - OneMedNet Corp (0001849380) (Issuer)

    11/15/23 4:18:48 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    New insider Kosasa Thomas claimed ownership of 4,952,409 shares (SEC Form 3)

    3 - OneMedNet Corp (0001849380) (Issuer)

    11/15/23 2:08:21 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    SEC Form 4: Owl Creek Asset Management, L.P. disposed of $5,175,450 worth of shares (465,000 units at $11.13)

    4 - Data Knights Acquisition Corp. (0001849380) (Issuer)

    8/21/23 6:18:49 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $DKDCA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    OneMedNet Network Expands with New Partnership with Large Academic Research Medical Center to Benefit its Life Science Company Clients

    ~ Partnership To Leverage Real World Data for Life Science Innovation Accelerating New Diagnostic and Treatment Solutions ~MINNEAPOLIS, MN / ACCESSWIRE / November 9, 2023 / OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet"), the leading curator of regulatory-grade imaging Real World Data ("RWD"), today announced a new partnership with a leading research medical center to accelerate and expand development of new diagnostic and treatment solutions using OneMedNet's iRWD™. Life Science innovators, including pharmaceutical, AI, medical device, and clinical research organizations, are now able to effectively use existing real world data for discovery, development, regulatory-approval, and post-mar

    11/9/23 4:15:00 PM ET
    $DKDCA
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    OneMedNet Completes Business Combination with Data Knights Acquisition Corp. to Become a Publicly Traded Company

    OneMedNet Common Stock to Trade on Nasdaq Under Ticker "ONMD" Tomorrow, Wednesday, November 8, 2023OneMedNet to Fully Embark on its Growth Strategy as it Spearheads the Imaging RWD Solution in the $400 Billion Clinical MarketMINNEAPOLIS, MN / ACCESSWIRE / November 7, 2023 / OneMedNet Corporation (NASDAQ:DKDCA)(NASDAQ:DKDCW) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Imaging Real World Data ("RWD"), through its proven OneMedNet iRWD™ solution, today announced that it has completed its previously announced business combination with Data Knights Acquisition Corp. ("Data Knights"). The business combination was approved at a special meeting of Data Knights' stockholde

    11/7/23 2:00:00 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Data Knights Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination

    MINNEAPOLIS, MN and LONDON, UK / ACCESSWIRE / October 12, 2023 / Data Knights Acquisition Corp. ("Data Knights" or the "Company") (NASDAQ:DKDCU, DKDCA, DKDCW))), a special purpose acquisition company, today announced that on October 10, 2023 it caused to be deposited $75,000 into the Company's trust account, allowing the Company to extend the period of time it has to consummate its initial business combination by one month from October 11, 2023 to November 11, 2023 (the "Extension"). The Extension is the third of nine (9) one-month extensions permitted under the Company's governing documents. Cautionary Statement Regarding Forward-Looking StatementsThis press release contains statements

    10/12/23 4:45:00 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $DKDCA
    Leadership Updates

    Live Leadership Updates

    View All

    OneMedNet Appoints Healthcare IT Executive, Aaron Green, as President

    ~ Signaling a New Chapter of Growth for the Innovative Solution of Real World Data~MINNEAPOLIS, MN / ACCESSWIRE / May 23, 2023 / OneMedNet Corporation ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Imaging Real Word Data, through its proven OneMedNet iRWD™ solution, today announced the expansion of its executive team with the appointment of healthcare technology veteran, Aaron Green, as President. In this new role, Green will be responsible for all the major growth functions and lead engagement with existing clients, new clients, sales operations, marketing, communications, and product innovation, reporting directly to the CEO.Green is a healthcare technology busines

    5/23/23 4:05:00 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $DKDCA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Data Knights Acquisition Corp. (Amendment)

    SC 13G/A - OneMedNet Corp (0001849380) (Subject)

    2/14/24 6:03:43 AM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    SEC Form SC 13G/A filed by Data Knights Acquisition Corp. (Amendment)

    SC 13G/A - OneMedNet Corp (0001849380) (Subject)

    2/5/24 1:55:23 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    SEC Form SC 13G filed by Data Knights Acquisition Corp.

    SC 13G - Data Knights Acquisition Corp. (0001849380) (Subject)

    4/11/23 12:00:45 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care